Evidence map›Paper›PMID 32546694›Full record

Trial reportNature communications2020

Transplantation of discarded livers following viability testing with normothermic machine perfusion.

Hynek Mergental, Richard W Laing, Amanda J Kirkham, M Thamara P R Perera, Yuri L Boteon, Joseph Attard, Darren Barton, Stuart Curbishley, Manpreet Wilkhu, Desley A H Neil and 15 more

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02740608 (An Open Label, Non-randomised, Prospective, Single Arm, 2-part Trial, Using Normothermic Machine Liver Perfusion NMLP to Test Viability and Transplantation of Marginal Livers), which is not on this map. Cited by 210 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
210citing papers in PubMed, 6 pooled it
53.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02740608 nacompletednot on this map

An Open Label, Non-randomised, Prospective, Single Arm, 2-part Trial, Using Normothermic Machine Liver Perfusion NMLP to Test Viability and Transplantation of Marginal Livers

TypeinterventionalSponsorUniversity of BirminghamRan2016 to 2020Enrolled22ConditionsLiver TransplantationArmsOrganOx metra
3 · Its place in the literature

Who cites it

210 citing papers in PubMed, 6 syntheses or guidelines pooled it, 451 citations in OpenAlex.

  1. Pooled it
  2. Donor-Related Risk Factors for Normothermic Machine Perfusion in Liver Transplantation: A Meta-Analysis.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Biliary Viability Assessment and Treatment Options of Biliary Injury During Normothermic Liver Perfusion-A Systematic Review.Transplant international : official journal of the European Society for Organ Transplantation · 2022
    Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Proteomic Trajectories of Metabolic and Proteostatic Adaptation During Normothermic Liver Perfusion.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  20. Review

150 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 1 country.

Hynek Mergental *Liver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK. hynek.mergental@uhb.nhs.uk.ORCID http://orcid.org/0000-0001-5480-9380
Richard W Laing *Liver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.
Amanda J KirkhamCancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
M Thamara P R PereraLiver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.
Yuri L BoteonLiver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.ORCID http://orcid.org/0000-0002-1709-9284
Joseph AttardLiver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.
Darren BartonD3B team, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0003-0106-5861
Stuart CurbishleyNational Institute for Health Research (NIHR), Birmingham Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Manpreet WilkhuD3B team, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
Desley A H NeilNational Institute for Health Research (NIHR), Birmingham Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.ORCID http://orcid.org/0000-0001-9800-6811
Stefan G HübscherNational Institute for Health Research (NIHR), Birmingham Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Paolo MuiesanLiver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.
John R IsaacLiver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.
Keith J RobertsLiver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.
Manuel AbradeloLiver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.
Andrea SchlegelLiver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.
James FergusonLiver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.
Hentie CilliersLiver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.
Julian BionDepartment of Intensive Care Medicine, University of Birmingham, Birmingham, UK.
David H AdamsLiver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK.
Chris MorrisOrganOx Limited, Oxford, UK.ORCID http://orcid.org/0000-0001-9102-6668
Peter J FriendOrganOx Limited, Oxford, UK.
Christina Yap *Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-6715-2514
Simon C Afford *National Institute for Health Research (NIHR), Birmingham Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. S.C.AFFORD@bham.ac.uk.
Darius F Mirza *Liver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Birmingham, UK. darius.mirza@uhb.nhs.uk.ORCID http://orcid.org/0000-0002-7531-9089
University Hospitals Birmingham NHS Foundation Trust · GBCancer Research UK Clinical Trials Unit · GBInstitute of Cancer Research · GBOrganOx (United Kingdom) · GBUniversity of Birmingham · GBUniversity of Oxford · GB

Funding

Cancer Research UK C22436/A15958Wellcome TrustWellcome Trust 200121/B/15/Z
6 · The paper itself

Abstract

There is a limited access to liver transplantation, however, many organs are discarded based on subjective assessment only. Here we report the VITTAL clinical trial (ClinicalTrials.gov number NCT02740608) outcomes, using normothermic machine perfusion (NMP) to objectively assess livers discarded by all UK centres meeting specific high-risk criteria. Thirty-one livers were enroled and assessed by viability criteria based on the lactate clearance to levels ≤2.5 mmol/L within 4 h. The viability was achieved by 22 (71%) organs, that were transplanted after a median preservation time of 18 h, with 100% 90-day survival. During the median follow up of 542 days, 4 (18%) patients developed biliary strictures requiring re-transplantation. This trial demonstrates that viability testing with NMP is feasible and in this study enabled successful transplantation of 71% of discarded livers, with 100% 90-day patient and graft survival; it does not seem to prevent non-anastomotic biliary strictures in livers donated after circulatory death with prolonged warm ischaemia.

Indexed as

AgedFemaleGraft SurvivalHumansLiverLiver Function TestsLiver TransplantationMaleMiddle AgedNon-Randomized Controlled Trials as TopicOrgan PreservationPerfusionProspective StudiesSurvival AnalysisTemperatureTime Factors

Identifiers

PMID32546694
PMCPMC7298000
OpenAlexW3024418144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.